개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.9
- 수록면
- 1 - 11 (11page)
- DOI
- 10.1038/s12276-020-00500-y
이용수
초록· 키워드
오류제보하기
Cancer immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced cancers. However, the tumor microenvironment (TME) functions as a formidable barrier that severely impairs the efficacy of ICIs. While the crosstalk between tumor vessels and immune cells determines the nature of anti-tumor immunity, it is skewed toward a destructive cycle in growing tumors. First, the disorganized tumor vessels hinder CD8 + T cell trafficking into the TME, disable effector functions, and even kill T cells. Moreover, VEGF, the key driver of angiogenesis, interferes with the maturation of dendritic cells, thereby suppressing T cell priming, and VEGF also induces TOX-mediated exhaustion of CD8 + T cells. Meanwhile, a variety of innate and adaptive immune cells contribute to the malformation of tumor vessels. Protumoral M2-like macrophages as well as T H 2 and Treg cells secrete pro-angiogenic factors that accelerate uncontrolled angiogenesis and promote vascular immaturity. While CD8 + T and CD4 + T H 1 cells suppress angiogenesis and induce vascular maturation by secreting IFN-γ, they are unable to infiltrate the TME due to malformed tumor vessels. These findings led to preclinical studies that demonstrated that simultaneous targeting of tumor vessels and immunity is a viable strategy to normalize aberrant vascular-immune crosstalk and potentiate cancer immunotherapy. Furthermore, this combination strategy has been evidently demonstrated through recent pivotal clinical trials, granted approval from FDA, and is now being used in patients with kidney, liver, lung, or uterine cancer. Overall, combining anti-angiogenic therapy and ICI is a valid therapeutic strategy that can enhance cancer immunity and will further expand the landscape of cancer treatment.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
T Cell-mimicking Nanoparticles for Cancer Immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2021 .04
-
A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity
BMB Reports
2020 .01
-
Cancer immunotherapy: special issue of BMB Reports in 2021
BMB Reports
2021 .01
-
Engineering of tumor microenvironment on a chip for evaluating combination immunotherapy
대한기계학회 춘추학술대회
2021 .04
-
Engineering of vascularized 3D cancer on a chip modeling for drug delivery
대한기계학회 춘추학술대회
2021 .04
-
Single-cell RNA-Seq unveils tumor microenvironment
BMB Reports
2017 .06
-
Immune Cell Membrane-Coated Lipid Nanoparticles for Simultaneous Cancer Cell Death and Immune Cell Activation
한국생물공학회 학술대회
2023 .04
-
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity
BMB Reports
2023 .03
-
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy
BMB Reports
2024 .09
-
Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments
조직공학과 재생의학
2022 .04
-
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Nano Convergence
2022 .04
-
Extracellular vesicles in onco-nephrology
Experimental and Molecular Medicine
2019 .01
-
Tumor microenvironment and radioresistance
Experimental and Molecular Medicine
2021 .06
-
In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids
조직공학과 재생의학
2020 .01
-
In vitro Tumor Vasculature Model of the Colorectal Cancer Microenvrionment to Evaluate Natural Killer Cell Activity
대한기계학회 춘추학술대회
2021 .04
-
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Experimental and Molecular Medicine
2024 .01
-
Acetate decreases PVR/CD155 expression via PI3K/AKT pathway in cancer cells
BMB Reports
2021 .08
-
The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer
BMB Reports
2022 .01
-
The contribution of the nervous system in the cancer progression
BMB Reports
2024 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0